欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7033/001
药品名称Ospolot 20 mg/ml Suspension zum Einnehmen
活性成分
    • sultiame 20.0 mg/ml
剂型Oral suspension
上市许可持有人Desitin Arzneimittel GmbH Weg Beim Jäger 214 22335 Hamburg Germany
参考成员国 - 产品名称Germany (DE)
Ospolot 20 mg/ml Suspension zum Einnehmen
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Czechia (CZ)
      Ospolot 20 mg/ml Perorální suspenze
    • Denmark (DK)
      Ospolot
    • Estonia (EE)
    • Belgium (BE)
      Ospolot 20 mg/ml Suspension zum Einnehmen
    • Finland (FI)
    • Netherlands (NL)
    • Poland (PL)
    • Luxembourg (LU)
    • Romania (RO)
      Ospolot 20 mg/ml Suspensie orală
    • Ireland (IE)
    • Slovakia (SK)
    • Spain (ES)
许可日期2021/11/09
最近更新日期2024/05/06
药物ATC编码
    • N03AX03 sultiame
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase